EurekaMag.com logo
+ Translate

Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony


, : Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. International Journal of Dermatology 32(8): 610-612

Cutaneous leishmaniasis represents a difficult disease to manage in endemic areas. Systemic treatment is hampered by both expense and compliance. Side effects may play a major role in this aspect as well. The effectiveness of intralesional treatment of leishmaniasis was investigated. Seven hundred and ten patients were treated with injections of sodium stibogluconate intralesionally. The clinical diagnosis was confirmed by demonstrating the parasite in the smears obtained from the lesion. Fine insulin needle was used to infiltrate the lesion with sodium stibogluconate (0.5 to 1.0 mL). Generally eight injections were sufficient, but some of the complicated lesions needed up to 24 injections. Sixty-two percent of patients were men. The majority of the study population (64%) were children below 15 years of age. The results showed that 72% of lesions healed completely, 23.9% showed some improvement, while 4.1% showed some deterioration. Lesions of the lips, cheeks, chin, and neck healed faster than lesions in other parts of the body. Side effects were mild and limited to pain at the site of the injection and hyperpigmentation in those who were treated by folk medicine. Intralesional treatment is as effective as the standard systemic antimonials. It offers a less expensive alternative and a low side effects profile. Our findings confirmed the findings of earlier workers. It is recommended for treatment of cutaneous leishmaniasis in endemic areas.

Accession: 002416159

PMID: 8407083

DOI: 10.1111/j.1365-4362.1993.tb05044.x

Download PDF Full Text: Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Sharquie K.E.; A.T.lib K.K.; Chu A.C., 1988: Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. One hundred and thirty lesions of cutaneous leishmaniasis in 60 patients were treated with intralesional injections of Pentostam and 30 lesions were left untreated as controls. The injections were given at 8-day intervals and the patients followed...

El-Sayed, M.; Anwar, A.E., 2010: Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. Background: Cutaneous leishmaniasis (CL) is a disease caused by leishmania species. Intralesional sodium stibogluconate (SSG) has been considered the first line therapy for localized cutaneous leishmaniasis. There is still a need for more effectiv...

Solomon, M.; Baum, S.; Barzilai, A.; Pavlotsky, F.; Trau, H.; Schwartz, E., 2009: Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. Cutaneous leishmaniasis is endemic in Israel. Leishmania major is the most prevalent species that cause cutaneous leishmaniasis. Current treatment options are limited and there are few investigations in search of alternative ones. This study aims...

Tallab, T.M.; Bahamdam, K.A.; Mirdad, S.; Johargi, H.; Mourad, M.M.; Ibrahim, K.; E.S.erbini, A.H.; Karkashan, E.; Khare, A.K.; Jamal, A., 1996: Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate. The efficacies of 3 different intralesional schedules with sodium stibogluconate were investigated in the treatment of cutaneous leishmaniasis. 96 patients in Saudi Arabia with 129 lesions were entered into the study, all with confirmed diagnosis...

A.Qubati, Y., 1997: Cutaneous leishmaniasis from Yemen: treatment with intralesional injection of sodium stibogluconate with local anesthetic. Intralesional injections of 0.25 to 0.5 ml sodium stibogluconate mixed with an equivalent amount of local anaesthetic (2% lidocaine) was successfully used to treat cutaneous leishmaniasis in Yemen. This procedure was repeated twice weekly for 4 to...

Ranawaka, R.R.; Weerakoon, H.S., 2010: Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani. Since cutaneous leishmaniasis (CL) is a self healing disease, an ideal therapy should be rapidly effective, easily administered, cheap, available at all times at all centers and should have no side effects. To determine the efficacy and safety of...

Bumb, R.A.; Mehta, R.D.; Ghiya, B.C.; Jakhar, R.; Prasad, N.; Soni, P.; Lezama-Davila, C.; Satoskar, A.R., 2011: Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India. Cutaneous leishmaniasis (CL) is caused by Leishmania major and L. tropica in the old world. Bikaner, the 'Thar Desert', situated in the north-western corner of India, is an endemic pocket for CL caused by L. tropica. Skin lesions of CL h...

Ranawaka, R.R.; Weerakoon, H.S.; de Silva, S.H.Padmal., 2016: Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis. Intralesional 7% hypertonic saline (HS) has been shown to be effective and safe against Leishmania donovani and Leishmania major cutaneous leishmaniasis (CL), with cure rates of 92% and 96%, respectively. This study was designed to assess the effi...

Asilian, A.; Sadeghinia, A.; Faghihi, G.; Momeni, A.; Amini Harandi, A., 2003: The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. It would be very useful to have a more effective and more rapid method available for the treatment of cutaneous leishmaniasis (CL). The main aim of the present study was to see if the combination of cryotherapy and intralesional injections with me...

Jaser, M.A.; E.Y.zigi, A.; Kojan, M.; Croft, S.L., 1994: Antimony in cutaneous leishmaniasis lesions after sodium stibogluconate administration. Pharmaceutical Research (New York) 11(10 SUPPL ): S373